Surviving breast cancer is both a physical and an emotional ordeal, but the consensus among researchers is that life generally returns to normal for most women within two years of completing treatment.
If you are one of the 370,000 Americans who lack functioning kidneys, you are all too familiar with the exhausting procedure of kidney dialysis. Three or four times every week, you visit a special clinic and sit for four hours as your blood is removed, cleaned and returned to your body.
The U.S. Food and Drug Administration (FDA) announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients? heart valves.
Berlex, Microsoft, and the National Multiple Sclerosis Society Embark on Landmark Collaboration to Help People with MS Maintain Their Health and Stay Connected.
The Canadian Food Inspection Agency (CFIA) and Excelsior Foods Inc. are warning the public not to consume Marcella?s Garden brand Olives described below because these products may be contaminated with Clostridium botulinum. Toxins produced by this bacteria may cause botulism, a life-threatening illness.
A measure of cardiac regulation called “heart rate variability” (HRV) appears to be linked to self regulation. HRV was considerably higher when people were working to resist temptation.
Sutent (sunitinib malate) has received a European Association of Urology recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma.
Cutting junior doctors’ working hours and giving them more rest breaks won’t by itself reduce fatigue or the attendant risk of error, concludes a study published ahead of print in Occupational and Environmental Medicine.
A new photographic exhibit, called ?The Image of MS? has been unveiled at the Ara Pacis Museum in Rome to dispel myths about multiple sclerosis (MS), challenge public perceptions about the disease, and encourage those with symptoms to seek treatment as early as possible.
The U.S. Food and Drug Administration (FDA) approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death. Soliris is classified as an Orphan Drug and is a new molecular entity containing an ingredient not previously marketed in the United States.